newsfilter
← Latest News
GlobeNewswire·

Vigil Neuroscience to Present at Jefferies Inaugural Biotech CNS/Neuro Summit

WATERTOWN, Mass., Oct. 05, 2023 (GLOBE NEWSWIRE) -- Vigil Neuroscience, Inc. (NASDAQ:VIGL), a clinical-stage biotechnology company committed to harnessing the power of microglia for the treatment of neurodegenerative